Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / MED BREAKTHGH
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
1,618,337
-
Shares change
-
+66,434
-
Total reported value, excl. options
-
$67,537,782
-
Value change
-
+$2,754,720
-
Put/Call ratio
-
0%
-
Number of buys
-
14
-
Number of sells
-
-28
-
Price
-
$42.24
Significant Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q4 2021
71 filings reported holding SBIO - ALPS ETF TR - MED BREAKTHGH as of Q4 2021.
ALPS ETF TR - MED BREAKTHGH (SBIO) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,618,337 shares
.
Largest 10 shareholders include MORGAN STANLEY (233,461 shares), UBS Group AG (221,540 shares), WELLS FARGO & COMPANY/MN (207,392 shares), BANK OF AMERICA CORP /DE/ (175,246 shares), Phoenix Holdings Ltd. (146,900 shares), Matisse Capital (142,044 shares), NTV Asset Management LLC (62,308 shares), LPL Financial LLC (44,078 shares), ROYAL BANK OF CANADA (36,005 shares), and COMMONWEALTH EQUITY SERVICES, LLC (30,014 shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.